Name | (3α,5β,6β,7β)-3,6,7-Trihydroxycholan-24-oic acid |
---|---|
Synonyms | 2-Cyan-3-(3-methylphenyl)-2-butensaeure-ethylester |
Description | β-Muricholic acid is a potent and orally active biliary cholesterol-desaturating agent. β-Muricholic acid prevents cholesterol gallstones. β-Muricholic acid inhibits lipid accumulation. β-Muricholic acid has the potential for the research of nonalcoholic fatty liver disease (NAFLD)[1][2]. |
---|---|
Related Catalog | |
In Vitro | β-Muricholic acid (100µM; 48 h) 抑制小鼠原代肝细胞中的脂质积累[1]。 |
In Vivo | β-Muricholic acid (用 0.5% β-鼠胆酸喂食 8 周) 可预防小鼠的饮食诱导或实验性胆固醇胆结石[2]。 Animal Model: 6-8 weeks, Male C57L/J mice (with a lithogenic diet (2% cholesterol and 0.5% cholic acid))[2] Dosage: 0.5% β-muricholic acid Administration: Fed chow with 0.5% β-muricholic acid for 8 weeks Result: Decreased gallstone prevalence to 20% through significantly reducing biliary secretion rate, saturation index, and intestinal absorption of cholesterol, as well as inducing phase boundary shift and an enlarged Region E that prevented the transition of cholesterol from its liquid crystalline phase to solid crystals and stones. |
References |
Density | 1.184g/cm3 |
---|---|
Boiling Point | 565.7ºC at 760mmHg |
Molecular Formula | C24H40O5 |
Molecular Weight | 408.57100 |
Flash Point | 310ºC |
Exact Mass | 408.28800 |
PSA | 97.99000 |
LogP | 3.44870 |
Vapour Pressure | 3.75E-15mmHg at 25°C |
Index of Refraction | 1.558 |